CNS Drug Reviews logo Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 12, Number 1, March 2006

all issues | next issue >

Bryostatin-1: Pharmacology and Therapeutic Potential as a CNS Drug
pp. 1-8(8)
Authors: Sun, Miao-Kun; Alkon, Daniel L.

Neuroprotective Effects of Edaravone: a Novel Free Radical Scavenger in Cerebrovascular Injury
pp. 9-20(12)
Authors: Yoshida, Hiroshi; Yanai, Hidekatsu; Namiki, Yoshihisa; Fukatsu-Sasaki, Kayoko; Furutani, Nobuyuki; Tada, Norio

Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597)
pp. 21-38(18)
Authors: Piomelli, Daniele; Tarzia, Giorgio; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Compton, Timothy R.; Dasse, Olivier; Monaghan, Edward P.; Parrott, Jeff A.; Putman, David

Pharmacological Characterization of DM232 (Unifiram) and DM235 (Sunifiram), New Potent Cognition Enhancers
pp. 39-52(14)
Authors: Romanelli, M. N.; Galeotti, N.; Ghelardini, C.; Manetti, D.; Martini, E.; Gualtieri, F.

A New Look at the 5α-Reductase Inhibitor Finasteride
pp. 53-76(24)
Authors: Finn, Deborah A.; Beadles-Bohling, Amy S.; Beckley, Ethan H.; Ford, Matthew M.; Gililland, Katherine R.; Gorin-Meyer, Rebecca E.; Wiren, Kristine M.

Neuroprotective Activity of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (PAN-811), a Cancer Therapeutic Agent
pp. 77-90(14)
Authors: Jiang, Zhi-Gang; Lebowitz, Michael S.; Ghanbari, Hossein A.

all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page